Clinical Trial Update: REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Replens vaginal moisturizer to intra-vaginal estrogen for vaginal dryness in patients with estrogen receptor-positive breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Intra-vaginal estrogen (estradiol vaginal product)
• Replens

Snippet

Sponsor: Polly A. Niravath, MD | Conditions: Estrogen Receptor Positive Breast Cancer, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING